Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Janus kinase inhibitors may help treat lichen planopilaris.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Fipronil effectively treats Lynxacarus radovskyi in outdoor cats.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Lupus hepatitis can affect male SLE patients and is treatable with specific medications.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

The treatment was effective for advanced non-Hodgkin's lymphomas.

Leflunomide with prednisone is effective and well-tolerated for lupus nephritis when cyclophosphamide can't be used.

Ritlecitinib may help young adults with severe alopecia areata when ketoconazole doesn't work.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Avacopan is generally safe, with some minor side effects like nausea and fatigue.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Switching to generic tacrolimus was safe, effective, and saved money.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Cinacalcet may help treat hereditary vitamin D resistant rickets safely.

Researchers found several compounds that could potentially treat Zika virus.

A man's relapsed leprosy was successfully treated with the antibiotic sparfloxacin.

A patient developed a blister at the injection site after hepatitis C treatment.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

Hepatitis C treatment may trigger complete hair loss, especially in those with a history of patchy hair loss, but hair usually grows back within a year.

A girl developed vitiligo and psoriasis after hepatitis B treatment, and stopping the treatment didn't help.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Imatinib can cause hair loss due to lichen planopilaris.